Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Long-term Potentiation01:25

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...
Long-term Potentiation01:35

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Amnesia01:13

Amnesia

Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimising access to employment support for people with multiple sclerosis through charities: a qualitative study using Normalisation Process Theory.

BMC health services research·2026
Same author

Improving work outcomes in people with multiple sclerosis: A scoping review of non-pharmacological interventions.

Clinical rehabilitation·2026
Same author

Developing a job retention vocational rehabilitation intervention for people with long covid: a person-based approach.

BMJ open·2026
Same author

A novel device for in-situ on-demand hydrogen sulfide generation and delivery to increase tissue perfusion to chronic wounds.

Journal of biological engineering·2026
Same author

Mixed-methods non-randomised single-arm feasibility study assessing delivery of a remote vocational rehabilitation intervention for patients with serious injury: the ROWTATE study.

BMJ open·2025
Same author

Digital cognitive behavioral therapy for insomnia compared with digital patient education about insomnia in people with multiple sclerosis in Norway: study protocol for a randomized controlled trial.

Sleep advances : a journal of the Sleep Research Society·2025

Related Experiment Video

Updated: May 24, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Memory Rehabilitation for people with multiple sclerosis.

Roshan das Nair1, Heather Ferguson, Daniel L Stark

  • 1Institute of Work, Health & Organisations, University of Nottingham, Nottingham, UK.roshan.nair@nottingham.ac.uk.

The Cochrane Database of Systematic Reviews
|March 16, 2012
PubMed
Summary

Memory rehabilitation does not improve memory or daily function in Multiple Sclerosis (MS) patients. More high-quality randomized controlled trials (RCTs) are needed to confirm these findings.

More Related Videos

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Related Experiment Videos

Last Updated: May 24, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Area of Science:

  • Neurorehabilitation
  • Cognitive Science
  • Clinical Trials

Background:

  • Memory impairments are common in Multiple Sclerosis (MS) and impact functional abilities.
  • Previous small studies suggested memory rehabilitation benefits, but randomized controlled trials (RCTs) yielded inconclusive results.

Purpose of the Study:

  • To evaluate the effectiveness of memory rehabilitation for MS patients with memory deficits.
  • To assess the impact of memory rehabilitation interventions on patients' functional abilities.

Main Methods:

  • Systematic search of multiple databases and trial registers for relevant RCTs.
  • Inclusion criteria focused on RCTs comparing memory rehabilitation with control groups in MS patients.
  • Meta-analysis and 'best evidence' synthesis were used for data analysis, with rigorous quality assessment.

Main Results:

  • Eight RCTs involving 521 participants were analyzed, with generally low risk of bias.
  • Memory rehabilitation showed no significant immediate or long-term effects on memory function, mood, or quality of life.
  • While no immediate effect was seen on Activities of Daily Living, long-term follow-up indicated worse performance in the intervention group.

Conclusions:

  • Current evidence does not support the effectiveness of memory rehabilitation for improving memory or function in MS patients.
  • The limited quality of some primary studies necessitates caution in interpreting results.
  • Further high-quality RCTs with robust methodology and reporting are required to definitively assess treatment efficacy.